GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Thetimefarm@lemm.eeEnglish
    56·
    9 months ago

    As long as it's for research and stays HIPPA compliant I don't really have an issue with it. This would be a good use for AI but that's also kinda horrifying to think about. Having millions of unique human DNA samples to train your AI on would be worth something I presume.

    • ohlaph@lemmy.worldEnglish
      41·
      9 months ago

      If they used it to help people, yes. But they're going to charge for whatever they create.